PlasmaMed - The hallmark of a National Brand product from the aspiration to master biomedical technology
News

PlasmaMed - The hallmark of a National Brand product from the aspiration to master biomedical technology

15/10/2026 09:47 PM

In the context of Viet Nam's healthcare sector facing the demand for technological innovation and improving treatment quality, the emergence of 'Make in Viet Nam' products with high scientific content not only contributes to improving healthcare efficiency but also affirms the research capacity and technology mastery of domestic enterprises.

Pioneer in bringing cold plasma into biomedicine

Vietnam Plasma Technology Joint Stock Company is the pioneer in Viet Nam to research, invent and apply sliding arc cold plasma technology in the biomedical field through the typical product PlamaMed. This is an important advancement in wound treatment, helping to increase antibacterial effectiveness, promote tissue regeneration, and shorten recovery time for patients.

After more than 10 years of formation and development, the enterprise has continuously invested in research, perfected technology, and expanded practical applications. To date, cold plasma treatment techniques by PlamaMed have been implemented in over 500 medical facilities nationwide, covering all 34 provinces and cities, contributing to reducing the burden on the healthcare system, while saving treatment costs for people.

The achievements not only demonstrate technological capability but also affirm the enterprise's responsibility to the community. With this foundation, PlamaMed continues sustainable development, aiming to maintain the position of a National Brand product for many consecutive years, including the 2026 selection period.

PlasmaMed - The hallmark of a National Brand product from the aspiration to master biomedical technology - Ảnh 3.
Cold plasma is a technology for wound treatment, helping to increase antibacterial effectiveness, promote tissue regeneration, and shorten recovery time for patients.

Towards a high-tech science enterprise

Not stopping at the role of a science and technology enterprise, Vietnam Plasma Technology Joint Stock Company is gradually elevating to become a high-tech science enterprise in Viet Nam. This is reflected through a systematic investment strategy in research and development (R&D), cooperation with institutes, universities, and expert teams domestically and internationally.

The company's goal is not only to master cold plasma technology but also to expand applications into other biomedical fields, contributing to forming a modern 'Made in Vietnam' medical technology ecosystem. This direction also aligns with the Party and State's policy on economic development based on science, technology, and innovation.

Choosing the path of sustainable development, respecting the law

PlamaMed is regarded as one of the typical pioneering products in applying science and technology to healthcare with criteria of effectiveness-safety-reliability in the Vietnamese market.

Besides research and development activities, the company's leadership always emphasizes the spirit of respecting the law, strictly complying with the Party and State policies in all production and business activities. Especially in the medical device field - which demands high standards for safety and effectiveness, the company always fully complies with regulations on management, inspection, and circulation of products.

While the market reality still sees some units deliberately circumventing regulations on medical device management to self-declare medical device standards in an uncontrolled manner, even lowering risk levels, lacking clinical evidence, and facing penalties and revocation of declarations, PlamaMed chooses a systematic, transparent development path.

Notably, while many cold plasma devices on the market are classified as type B to facilitate circulation, PlamaMed is the first cold plasma device in Vietnam certified by the Ministry of Health as type C circulation - a classification level with higher requirements for safety and effectiveness validation.

Moreover, the technique of using the device has been issued by the Ministry of Health with clear technical lists and procedures under Decision 1007/QD-BYT and Circular 23/2024/TT-BYT, providing a solid legal and professional basis for deploying treatment of diseases, skin injuries, and burns by sliding arc cold plasma.

PlasmaMed - The hallmark of a National Brand product from the aspiration to master biomedical technology - Ảnh 4.
PlamaMed is the first cold plasma device in Viet Nam certified by the Ministry of Health as type C circulation - a classification level with higher requirements for safety and effectiveness validation.

Affirming national product stature

In the increasingly fierce competition and rising demands for medical device quality, PlamaMed is not only a technological product but also evidence of the creativity capacity of Vietnamese enterprises.

Achieving the National Brand title is not only recognition of quality and reputation but also poses greater responsibility to maintain standards, enhance value, and contribute to society. With sustainable development orientation, legal compliance, and patient-centered approach, PlamaMed is gradually asserting the role of a biomedical technology product of national stature, helping to extend Vietnamese intelligence on the world medical technology map.

You may be interested in